Stifel Financial Corp Spring Works Therapeutics, Inc. Transaction History

Stifel Financial Corp

$93.7 Billion
Q4 2024

A detailed history of Stifel Financial Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 23,713 shares of SWTX stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,713

Previous 25,681 7.66%

Holding current value

$1.18 Million

Previous $822,000 4.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$28.61 - $42.55 $56,304 - $83,738	-1,968 Reduced 7.66%	23,713 $856,000
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $48,444 - $64,653	-1,512 Reduced 5.56%	25,681 $822,000
Q2 2024 Aug 13, 2024	BUY	$36.06 - $47.62 $242,900 - $320,768	6,736 Added 32.93%	27,193 $1.02 Million
Q1 2024 May 13, 2024	BUY	$36.5 - $52.5 $82,161 - $118,177	2,251 Added 12.36%	20,457 $1.01 Million
Q4 2023 Feb 12, 2024	SELL	$18.94 - $37.24 $60,077 - $118,125	-3,172 Reduced 14.84%	18,206 $664,000
Q3 2023 Nov 13, 2023	BUY	$23.12 - $31.38 $6,103 - $8,284	264 Added 1.25%	21,378 $494,000
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $132,834 - $187,689	5,738 Added 37.32%	21,114 $553,000
Q1 2023 May 12, 2023	BUY	$24.97 - $34.05 $16,005 - $21,826	641 Added 4.35%	15,376 $395,000
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $27,857 - $36,819	-1,282 Reduced 8.0%	14,735 $383,000
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $4,265 - $7,019	-177 Reduced 1.09%	16,017 $457,000
Q2 2022 Aug 15, 2022	BUY	$18.36 - $60.07 $54,676 - $178,888	2,978 Added 22.53%	16,194 $399,000
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $3,036 - $4,058	-62 Reduced 0.47%	13,216 $746,000
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $231,481 - $329,373	4,343 Added 48.61%	13,278 $823,000
Q3 2021 Nov 15, 2021	BUY	$62.66 - $88.26 $388,178 - $546,770	6,195 Added 226.09%	8,935 $566,000
Q1 2021 May 14, 2021	SELL	$65.1 - $93.59 $610,247 - $877,312	-9,374 Reduced 77.38%	2,740 $202,000
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $585,833 - $943,922	12,114 New	12,114 $878,000

Others Institutions Holding SWTX

# of Institutions

236

Shares Held

67.2M

Call Options Held

260K

Put Options Held

316K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.11B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Spring Works Therapeutics, Inc. Transaction History